about
Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.The functional characteristics CCNI modulation of myeloid- derived suppressor cells in liver inflammation.The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis.Unmet challenges in immune-mediated hepatobiliary diseases.
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Autoimmune hepatitis: 50 Years of (slow) progress.
@en
Autoimmune hepatitis: 50 Years of
@nl
type
label
Autoimmune hepatitis: 50 Years of (slow) progress.
@en
Autoimmune hepatitis: 50 Years of
@nl
prefLabel
Autoimmune hepatitis: 50 Years of (slow) progress.
@en
Autoimmune hepatitis: 50 Years of
@nl
P2860
P356
P1433
P1476
Autoimmune hepatitis: 50 Years of (slow) progress.
@en
P2093
Edward L Krawitt
P2860
P304
P356
10.1002/HEP.26682
P407
P577
2014-03-01T00:00:00Z